A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older. (Q45995909)
Jump to navigation
Jump to search
scientific article published on 21 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older. |
scientific article published on 21 May 2009 |
Statements
1 reference
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older. (English)
1 reference
Giovanni Martinelli
1 reference
Hervé Dombret
1 reference
Wieslaw W Jedrzejczak
1 reference
Tadeusz Robak
1 reference
Jean-Luc Harousseau
1 reference
Joseph M Brandwein
1 reference
Dominique Bordessoule
1 reference
Tamas Masszi
1 reference
Gert J Ossenkoppele
1 reference
Julia A Alexeeva
1 reference
Gernot Beutel
1 reference
Johan Maertens
1 reference
Maria-Belen Vidriales
1 reference
Xavier Thomas
1 reference
Alan K Burnett
1 reference
Nuriet K Khuageva
1 reference
Anatoly K Golenkov
1 reference
Elena Tothova
1 reference
Lars Mollgard
1 reference
Youn C Park
1 reference
Annick Bessems
1 reference
Peter De Porre
1 reference
Angela J Howes
1 reference
FIGHT-AML-301 Investigators
1 reference
21 May 2009
1 reference
1 reference
114
1 reference
6
1 reference
1166-1173
1 reference
Identifiers
1 reference